Transplantologiya 2014

References
1. McQuitty C.K. Con: Inhaled nitric oxide should not be used routinely in patients undergoing lung transplantation. J. Cardiothorac. Vasc. Anesth. 2001; 15, (6): 790–792.

2. Marczin N. The biology of exhaled nitric oxide (NO) in ischemia-reperfusion-induced lung injury: a tale of dynamism of NO production and consumption. Vascul. Pharmacol. 2005; 43 (6): 415–424.

3. Yamashita H., Akamine S., Sumida Y., [et al.]. Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung. Ann. Thorac. Surg. 2004; 78 (1): 292–297.

4. Rossaint R., Falke K.J., Lopez F., [et al.]. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 1993; 328 (6): 399–405.

5. Della Rocca G., Pugliese F., Antonini M., [et al.]. Hemodynamics during inhaled nitric oxide in lung transplant candidates. Transplant Proc. 1997; 29 (8): 3367–3370.

6. Rocca G.D., Coccia C., Pugliese F., [et al.]. Intraoperative inhaled nitric oxide during anesthesia for lung transplant. Transplant Proc. 1997; 29 (8): 3362–3366.

7. Meyer K.C., Love R.B., Zimmerman J.J. The therapeutic potential of nitric oxide in lung transplantation. Chest. 1998; 113 (5): 1360–1371.

8. Ichinose F., Roberts Jr. J.D., Zapol W.M. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation. 2004; 109 (25): 3106–3111.

9. Young J.D., Sear J.W., Valvini E.M. Kinetics of methaemoglobin and serum nitrogen oxide production dur-ing inhalation of nitric oxide in volunteers. Br. J. Anaesth. 1996; 76 (5): 652–656.

10. Weinberger B., Laskin D.L., Heck D.E., Laskin J.D. The toxicology of inhaled nitric oxide. Toxicol. Sci. 2001; 59 (1): 5–16.

11. Golikov P.P., Nikolaeva N.Yu. Metod opredelenija nitrita/nitrata (NOx) v syvorotke krovi [Method for determination of nitrite/nitrate (NOx) in serum]. Biomed. himiya. 2004; 1: 79–85. (In Russian).

12. Steudel W., Hurford W.E., Zapol W.M. Inhaled nitric oxide: basic biology and clinical applications. Anesthesiology. 1999; 91 (4): 1090–1121.

13. De Andrade J.A., Crow J.P., Viera L., [et al.]. Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts. Crit. Care Med. 2000; 161 (6): 2035–2042.

14. De Andrade J.A., Crow J., Viera L., [et al.]. Reactive nitrogen species, airway inflammation, and fibrosis in lung transplant. Chest. 2001; 120 (1): S58–S59.

15. Reid D., Snell G., Ward C., [et al.]. Iron overload and nitric oxide-derived oxidative stress following lung transplantation. J. Heart Lung Transplant. 2001; 20 (8): 840–849.

16. Wiklund L., Lewis D.H., Sjöquist P.O., [et al.]. Increased levels of circulating nitrates and impaired endothelium-mediated vasodila-tion suggest multiple roles of nitric oxide during acute rejection of pulmonary allografts. J. Heart Lung Transplant. 1997; 16 (5): 517–523.

17. Worrall N.K., Boasquevisque C.H., Misko T.P., [et al.]. Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J. Heart Lung Transplant. 1997; 16 (3): 334–339.